Clinical inputs
Understand the result,
not just the number.
Genetic Risk Score (GRS13) for Lipid Disorders: Explanation and Clinical Context The GRS13 is a polygenic risk score calculated from 13 single nucleotide polymorphisms (SNPs) associated with lipid abnormalities, including elevated LDL-C, low HDL-C, and hypertriglyceridemia. Each SNP contributes to the score based on the number of risk alleles (0,1,2) and their effect sizes derived from genome-wide association studies. The total score stratifies individuals according to their genetic predisposition to dyslipidemia, which can complement traditional clinical risk assessment and guide early prevention strategies.
Higher scores suggest a greater likelihood of developing lipid disorders and may inform personalized lifestyle or pharmacologic interventions.
- Source 1
Talmud PJ, et al. "Use of a multi-locus genetic risk score for lipid disorders to identify high-risk individuals." J Lipid Res. 2010;51:2765-2772. doi:10.1194/jlr.P007158
Loading discussion…